HIV/AIDS cure is needed to end the infection that is destroying the immune system of infected individuals. Human Immunodeficiency Virus a retrovirus that reproduces once and creates more viruses until the cell burst and infects new cells.
This is why it can spread easily and lead to stage IV and cause the death of the patient. But fortunately, in the last 40 years, HIV/AIDS has gone from an unknown deadly disease to a manageable condition that even allowed patients to live longer and enjoy healthy living again.
The treatments
Although the exact drug or HIV/AIDS cure has not been found yet, there are many types of treatments and medications available for patients these days. It should be noted that if HIV is left untreated, it can progress to become the fatal Acquired Immunodeficiency Syndrome (AIDS), so early treatment is always a must.
Currently, one of the available drugs given to the patients is the antiretroviral drugs. It is a medication that prevents the virus from reproducing in the body and lowers the number of HIV as well.
It was observed that the continuous taking of this ARV drug could also avert contagion. According to the World Health Organization, it can lessen the risk of transmission by 96%.
There is also the drug called the azidothymidine, and this was formulated in 1987. It can block the enzyme that plays a big role in HIV’s duplication. As of today, 55 drugs have been approved by the FDA as an HIV/AIDS cure.
The most recent breakthrough is the stem cell transplant that already cured two AIDS patients. However, more tests are needed because this was also tried on other patients, but so far, only two people have gotten rid of the virus completely.
Ending the HIV epidemic
Last year, President Donald Trump stated in his SOTU that one of his administration’s goals is to put an end to the HIV epidemic and promised that they will realize this in 10 years. As per HIV.gov, the POTUS mentioned this week that his administration has taken steps and started working private businesses and partners find HIV/AIDS cure and stop the infection.


FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 



